| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d06ca458d89e6d0d52928afc5576079f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-226 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2016-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c98887ca92f568b2ac1ba422d341b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e096143cac015ca616ce4eefe6c4956 |
| publicationDate |
2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3332257-A1 |
| titleOfInvention |
Method for diagnosisng cancer or cancer-associated thrombosis by measuring levels of h3cit in plasma |
| abstract |
The present invention is related to a method for screening for the presence of cancer and several other indications in an individual comprising the steps of providing a plasma sample to be tested from the individual; and measuring the presence and/or quantity in the plasma sample of a biomarker chosen from citrullinated histone H3 (H3Cit), wherein said presence and/or quantity in the test sample of said biomarker chosen from citrullinated histone H3 (H3Cit) is indicating cancer in said individual. |
| priorityDate |
2015-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |